OncoCyte Announces Sponsored Symposium at the 2016 American College of Chest Physician’s CHEST 2016 Annual Meeting
24 oct. 2016 06h00 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests for the detection of cancer, today announced that it...
OncoCyte and The Wistar Institute Present Lung Cancer Diagnostic Data at the CHEST 2016 Annual Meeting
17 oct. 2016 05h00 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Oct. 17, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests for the early detection of cancer, and The Wistar...
OncoCyte Corporation to Present at the BIO Investor Forum
14 oct. 2016 06h30 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Oct. 14, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that William...
OncoCyte Corporation to Present at the 2016 Aegis Growth Conference
20 sept. 2016 06h30 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that William...
OncoCyte to Present Initial Data on its Breast Cancer Diagnostic Test at the Prestigious San Antonio Breast Cancer Symposium
08 sept. 2016 06h00 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced that its breast...
OncoCyte Corporation to Present at the Annual Gateway Conference
07 sept. 2016 06h30 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that William...
Don M. Bailey Appointed to OncoCyte Corporation’s Board of Directors
29 août 2016 16h15 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Aug. 29, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood and urine based tests for the early detection of cancer, today...
OncoCyte Corporation Announces the Closing of Two Private Placement Transactions Generating Gross Proceeds of $10.55 Million
29 août 2016 16h05 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Aug. 29, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that...
OncoCyte Reports Second Quarter 2016 Financial Results
11 août 2016 16h01 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, today reported its...
OncoCyte Commences Analytical Verification Study for Lung Cancer Diagnostic Test
10 août 2016 06h30 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, today announced that...